These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22563190)

  • 1. Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells.
    Jiang L; Lai YK; Zhang JF; Chan CY; Lu G; Lin MC; He ML; Li JC; Kung HF
    World J Gastroenterol; 2012 May; 18(17):2035-42. PubMed ID: 22563190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells.
    Jiang L; Chen Y; Chan CY; Wang X; Lin L; He ML; Lin MC; Yew DT; Sung JJ; Li JC; Kung HF
    Cancer Lett; 2009 Feb; 274(1):101-8. PubMed ID: 18930345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis.
    Hu ZC; Shi F; Liu P; Zhang J; Guo D; Cao XL; Chen CF; Qu SQ; Zhu JY; Tang B
    J Invest Dermatol; 2017 May; 137(5):1051-1059. PubMed ID: 28108300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis of human hepatoma cell lines induced by transforming growth factor beta 1 (TGF-beta1) correlates with p53 and Smad4 activation.
    Wang CL; Wan YL; Liu YC; Huang ZQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):176-8. PubMed ID: 16617361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1/SMAD signaling pathway mediates p53-dependent apoptosis in hepatoma cell lines.
    Wang CL; Wan YL; Liu YC; Huang ZQ
    Chin Med Sci J; 2006 Mar; 21(1):33-5. PubMed ID: 16615282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
    Dzieran J; Fabian J; Feng T; Coulouarn C; Ilkavets I; Kyselova A; Breuhahn K; Dooley S; Meindl-Beinker NM
    PLoS One; 2013; 8(8):e72252. PubMed ID: 23991075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
    Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
    Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC
    Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
    Li X; Zeng X
    Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
    Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
    PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme oxygenase-1/carbon monoxide axis suppresses transforming growth factor-β1-induced growth inhibition by increasing ERK1/2-mediated phosphorylation of Smad3 at Thr-179 in human hepatocellular carcinoma cell lines.
    Park SJ; Lee SK; Lim CR; Park HW; Liu F; Kim SJ; Kim BC
    Biochem Biophys Res Commun; 2018 Apr; 498(3):609-615. PubMed ID: 29524413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ERK1/2 Signaling Impairs the Promoting Effects of TGF-β1 on Hepatocellular Carcinoma Cell Invasion and Epithelial-Mesenchymal Transition.
    Liu L; Li N; Zhang Q; Zhou J; Lin L; He X
    Oncol Res; 2017 Nov; 25(9):1607-1616. PubMed ID: 28492136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
    World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X; Yang Y; Zhang X; Xu S; He S; Huang W; Roberts MS
    J Gastroenterol Hepatol; 2010 Feb; 25(2):420-6. PubMed ID: 19793165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of transforming growth factor-beta1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-beta/Smad pathway.
    Xiao J; Xiang Q; Xiao YC; Su ZJ; Huang ZF; Zhang QH; Tan Y; Li XK; Huang YD
    J Exp Clin Cancer Res; 2010 Apr; 29(1):35. PubMed ID: 20416076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
    Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
    Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region.
    Katabami K; Mizuno H; Sano R; Saito Y; Ogura M; Itoh S; Tsuji T
    Clin Exp Metastasis; 2005; 22(7):539-48. PubMed ID: 16475024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.